Process Control and Protocol Flexibility
Quantum uses several predefined tasks that can be customized to replicate the manual cell culture process for a range of adherent and suspension cells. Continuous media perfusion, temperature control, cell feeding and waste removal provide process control over the cell culture environment. Operators can monitor and adjust key cell culture process parameters via the touch screen. Cells are harvested in as little as 20 minutes.
Exercise Flexibility With Quantum, you can expand adherent and suspension cells and support plasmid transfections and viral transductions.
- Suspension cells: T cells, Dendritic cells, CD34+ cells
- Adherent cells: Mesenchymal stem cells (MSCs), Fibroblasts, iPSCs, neural stem cells
- Viral vectors: HEK 293T
Control Your Process
Quantum is a functionally closed, perfusion-based, automated cell expansion system that features reporting, user authentication and power failure recovery features, providing more control over the cell culture process.
Lower Risk of Contamination
Reduce up to 99.8% of open events associated with manual culture with a closed-cell culture environment.1
Enable Reproducible, Scalable Processes
In a study comparing MSC production in flasks versus the Quantum® Cell Expansion System, automation showed an 88% reduction in harvest time and labor hours.1
Interested in learning more?
Click here to receive more information or to get in contact a cell therapy technologies representative.
1. Hanley PJ, Mei Z, Durett AG, et al. Efficient manufacturing of therapeutic mesenchymal stromal cells with the use of the Quantum Cell Expansion System [published correction appears in Cytotherapy. 2014 Oct;16(10):1449. Cabreira-Harrison, Marie da Graca [corrected to Cabreira-Hansen, Maria da Graca]]. Cryotherapy. 2014;16(8):1048-1058. doi:10.1016/j.jcyt.2014.01.417
2. Tirughana R, Metz MZ, Li Z, et al. GMP Production and Scale-Up of Adherent Neural Stem Cells with a Quantum Cell Expansion System. Mol Ther Methods Clin Dev. 2018;10:48-56. Published 2018 Jul 7. doi:10.1016/j.omtm.2018.05.006